Dysfunctional protection against advanced glycation due to thiamine metabolism abnormalities in gestational diabetes

Serum carboxymethyl-lysine, a dominant advanced glycation end product, is increased in women with gestational diabetes mellitus

(2016) Vendula Bartakova et al.   BIOMEDICAL PAPERS-OLOMOUC

Metabolite Profiles During Oral Glucose Challenge

(2013) Jennifer E. Ho et al.   DIABETES

Current therapeutic interventions in the glycation pathway: evidence from clinical studies

(2012) L. Engelen et al.   DIABETES OBESITY & METABOLISM

Advanced Glycation End Products Are Direct Modulators of  -Cell Function

(2011) M. T. Coughlan et al.   DIABETES

Restriction of Advanced Glycation End Products Improves Insulin Resistance in Human Type 2 Diabetes: Potential role of AGER1 and SIRT1

(2011) J. Uribarri et al.   DIABETES CARE

Emerging role of thiamine therapy for prevention and treatment of early-stage diabetic nephropathy

(2011) N. Rabbani et al.   DIABETES OBESITY & METABOLISM

Advanced glycation endproducts: from precursors to RAGE: round and round we go

(2010) Ravichandran Ramasamy et al.   AMINO ACIDS

New Insights on Glucose Pathophysiology in Gestational Diabetes and Insulin Resistance

(2010) Avi Harlev et al.   Current Diabetes Reports

Role of thiamine status and genetic variability in transketolase and other pentose phosphate cycle enzymes in the progression of diabetic nephropathy

(2010) Lukáš Pácal et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

The relationship of serum AGE levels in diabetic mothers with adverse fetal outcome

(2009) L Guosheng et al.   Journal of Perinatology

Gestational diabetes: the need for a common ground

(2009) E Albert Reece et al.   LANCET

Type 2 diabetes mellitus after gestational diabetes: a systematic review and meta-analysis

(2009) Leanne Bellamy et al.   LANCET

Advanced Glycation End Products in Pregnancies Complicated with Diabetes Mellitus or Preeclampsia

(2008) Nina K. Harsem et al.   HYPERTENSION IN PREGNANCY